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Abstract: Edge Hill virus (EHV) is a mosquito-borne flavivirus isolated throughout Australia during mosquito surveillance programs. 
While not posing an immediate threat to the human population, EHV is a taxonomically interesting flavivirus since it remains the only 
member of the yellow fever virus (YFV) sub-group to be detected within Australia. Here we present both an antigenic and genetic inves-
tigation of collected isolates, and confirm taxonomic classification of the virus within the YFV-group. Isolates were not clustered based 
on geographical origin or time of isolation, suggesting that minimal genetic evolution of EHV has occurred over geographic distance 
or time within the EHV cluster. However, two isolates showed significant differences in antigenic reactivity patterns, and had a much 
larger divergence from the EHV prototype (19% nucleotide and 6% amino acid divergence), indicating a distinct subtype or variant 
within the EHV subgroup.
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Edge Hill virus (EHV) is a mosquito-borne  flavivirus 
that has been isolated during mosquito- surveillance 
programs conducted in the Northern Territory, 
 Queensland, Western Australia, and New South 
Wales.1–3 While the Flavivirus genus is known to har-
bor serious global pathogens such as yellow fever 
virus (YFV), West Nile virus (WNV) and the dengue 
viruses (DENV),4 EHV has only once been implicated 
in human disease. In this instance, virus symptoms 
included myalgia, arthralgia and fatigue.5 Generally, 
EHV sero-conversion by humans is rare,6 indicating 
the virus is of low risk to the human population. Indeed 
EHV has mainly been associated with marsupial infec-
tions, since antibodies reactive to EHV have been 
detected in wallabies, kangaroos and bandicoots.6,7
Taxonomically, EHV is a unique flavivirus since it 
remains the only member of the YFV sub-group to be 
detected within Australia. Adding to the interest, his-
torically the classification of EHV was briefly conten-
tious. The virus was originally classified within the 
Uganda S antigenic complex via cross- neutralization 
tests using polyclonal antisera,8,9 but later RNA 
hybridization studies suggested EHV might share up 
to 70% sequence homology with DENV-2 virus,10 
which belongs to a different antigenic clade.8,9 More-
over, monoclonal antibody 1B7, previously thought 
to be dengue specific, was found to cross-react with 
EHV in an ELISA,10 suggesting an antigenic simi-
larity between these viruses. Antigenic homology to 
DENV-2 could have serious implications for DENV 
detection and subsequent dengue hemorrhagic fever 
epidemiology within Australia.11 However, subse-
quent partial nucleotide sequencing of EHV did not 
confirm a relationship with DENV-2.12,13 Rather, 
sequencing confirmed a homology with other mem-
bers of the YFV group, and EHV is classified by the 
ICTV within this group.14 Geographically, the closest 
near-neighbour of EHV is Sepik virus (SEPV), which 
has been isolated in Papua New Guinea (PNG) but not 
in Australia.15,16 Reasons for the apparent geographic 
delineation of these viruses, and the notable absence 
of  YFV in both countries, presumably involve avail-
ability of mosquito vectors and host organisms. 
Additionally, the prevalence of one strain could be 
exclusionary to other related strains.
Since the original isolation of EHV in a suburb of 
Cairns in 1961, we and others have isolated the virus in 
Western Australia, Queensland, New South Wales, and 
the Northern Territory (Table 1). Here we present both 
an antigenic and genetic investigation of these isolates. 
For antigenic analysis, monoclonal antibodies to EHV 
were raised using either the C281 or the PH235 isolate, 
and for historical purposes we also tested antibodies 
raised to DENV-2, along with some reference DENV 
monoclonals17 (Table 2). Monoclonal antibody (mAb) 
binding patterns of isolates were determined by inocu-
lation of isolates onto confluent 96-well monolayers of 
C6/36 cells, incubation for up to 7 days, and subse-
quent assay by tissue culture enzyme immunoassay.18 
The four antibodies raised to C281 recognized all EHV 
isolates: 3D11 was found to be EHV-specific, while 
6A9 also recognized YFV, 7C6 cross-reacted with 
SEPV, and 8G2 reacted with both SEPV and Banzi 
virus (BANV). Of the antibodies produced to PH235, 
only 6F7 recognized all the EHV isolates. The remain-
ing antibodies (3B11, 3G1, 5D3, and 7C3) failed to 
recognize isolates P1553 and V366. Interestingly, with 
the exception of 6F7, which also recognized SEPV, 
the monoclonal antibodies produced to PH235 did not 
react with other flaviviruses used in this study. Finally, 
monoclonal antibodies raised to DENV-2 were also 
tested against EHV and a panel of flaviviruses. These 
antibodies were found to recognize only viruses within 
the dengue group, except for 1D1, which recognized 
all flaviviruses tested. Five reference dengue monoclo-
nal antibodies (15F3, 3H5, 5D4, 1H10 and 2H2) also 
failed to react with EHV.
Our monoclonal antibody analysis confirmed that 
EHV is antigenically similar to YFV, BANV and 
SEPV, and lacks antigenic similarity to DENV-2. 
Interestingly, the monoclonal antibodies created using 
the PH235-based immunogen had a different reac-
tion pattern compared to the antibodies induced by a 
C281-based immunogen, despite antigenic similar-
ity between both isolates. This difference in antibody 
panel reactivity is probably due to differences in mouse 
immunization procedures, since the PH235 antibod-
ies were created from immunizations with extracts 
of infected suckling mouse brain (see Supplementary 
Material, SM), whereas the C281- derived immuno-
gens comprised purified but inactivated virus cultured 
in Vero cells (D. Phillips, personal communication).
The most interesting observation from the antigenic 
studies was the distinct reaction pattern of isolates 
P1553 and V366, from Western Australia and the North-
ern Territory respectively. Testing against the panel of 
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C281-derived antibodies clearly indicated these isolates 
were antigenically more similar to the EHV prototype 
than our representative YFV, BANV and SEPV isolates, 
however they showed a distinct antigenic pattern from 
the EHV prototype when tested against the PH235-de-
rived antibody panel. These data indicate that P1553 and 
V366 represent a second antigenic subtype of EHV.
We subsequently performed a genetic investi-
gation of ehv isolates via nucleotide sequencing. 
Several consensus primers were tested for RT-PCR 
amplification of RNA extracted from EHV infected 
cell culture supernatant. Only one primer pair (FG1 
and FG2)19 successfully amplified any of the EHV 
isolates—yielding an approximately 1kb portion 
within the viral NS5 gene. The lack of amplification 
from the other primer pairs tested suggests signifi-
cant divergence of EHV from other more character-
ized flaviviruses. Indeed, the recent report of the full 
genomic sequence of a single strain of EHV, pub-
lished after the completion of the present study, has 
yielded  additional information on the evolution of 
EHV and other members of the YFV group, and will 
be useful for the design of improved flavivirus-group 
consensus primers throughout the genome.20
Nucleotide (Fig. 1) and amino acid (SM) sequence 
analysis of the amplified products indicated homo-
logy within the YFV group for all EHV isolates as 
expected, supported by 100% of bootstrap replicates. 
Moreover, despite geographic disparity, most EHV 
isolates had a very high degree of genetic similar-
ity, with less than 1% nucleotide (nt) divergence. 
Clustering based on geographic origin or time of 
isolation was not observed, indicating that genetic 
evolution within the EHV cluster has been minimal 
over geographic distance and time. However, iso-
lates P1553 and V366 showed a much larger diver-
gence from the EHV C281 prototype (19% nt and 6% 
amino acid divergence). This degree of divergence is 
larger than the genetic distance between Kunjin and 
West Nile viruses (11% nt and 1% amino acid diver-
gence), which are currently classified as separate sub-
types within the WNV virus species.14 However the 
divergence is  distinctly smaller than the divergence 
between DENV-1 and DENV-3 (72% nt), Murray 
Table 1. Details of Edge hill virus isolates used in this study.1
strain place of isolation Date of isolation source
C281* Edge hill (Cairns) QLD 1961 Cx. annulirostris
p1553 Marble Bar (pilbara region-WA) 16/3/94 Cx. ENM#92
GU0068 Normanton, QLD 13/4/2000 Ae. normanensis
ph235 Newman (pilbara region-WA) 18–21/3/79 Ae. bancroftianus
SW42148 Leschenault Inlet (South-West region-WA) 15/1/96 Ae. camptorhynchus
K22005 Broome (Kimberley region-WA) 28/3/96 Ae. vigilax
V366 Darwin, NT 5/1/83 Ae. vigilax
19542 unknown before 1976 unknown
22144 Batemans Bay (NSW) 17/1/95 Ae. vigilax
22441 Batemans Bay (NSW) 17/1/95 Ae. vigilax
22897 Batemans Bay (NSW) 23/1/95 Ae. vigilax
22905 Batemans Bay (NSW) 23/1/95 Ae. vigilax
22969 Batemans Bay (NSW) 23/1/95 Ae. vigilax
23056 Batemans Bay (NSW) 6/2/95 Ae. vigilax
23060 Batemans Bay (NSW) 6/2/95 Ae. vigilax
23072 Batemans Bay (NSW) 6/2/95 Ae. vigilax
23462 Batemans Bay (NSW) 14/2/95 Ae. vigilax
23543 Batemans Bay (NSW) 20/2/95 Ae. vigilax
23562 Batemans Bay (NSW) 20/2/95 Ae. vigilax
23703 Batemans Bay (NSW) 14/2/95 Ae. vigilax
24045 Tathra (NSW) 7/3/95 Ae. vigilax
24880 Ballina (NSW) 10/4/95 Ae. procax
25716 Maclean (NSW) 5/4/95 Ae. vigilax
26314 Boggabilla (NSW) 11/3/96 Cx. annulirostris
33029 port Stephens (NSW) 19/2/96 Ae. vigilax
*prototype strain.
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valley encephalitis virus (MVEV) and Alfuy virus 
(ALFV) (74% nt), and BANV and Uganda S virus 
(UGSV) (76% nt), indicating classification as a sepa-
rate virus is not warranted. Combined with our anti-
genic data, these results clearly indicate that isolates 
P1553 and V366 represent a distinct subtype or vari-
ant of EHV.
With only 2 representative strains, the origin and 
divergence of the EHV variant cannot be determined, 
but full-length sequence analysis could provide valu-
able information. Current data appears to preclude 
a recombination event, and the geographic location 
of the variant isolates indicates that they most likely 
 co-exist with the prototype strain. Such a coexistence 
of two EHV subtypes within the YFV group suggests 
that strain exclusion is perhaps an unlikely scenario for 
the absence of other YFV group viruses in  Australia. 
Recently Australia has seen the emergence of both 
Jev21 and a new KOKV-like virus,22 both of which 
are suspected to have been introduced from PNG. The 
determination of a second subtype of EHV, and detec-
tions of Sepik virus in PNG,15 indicate a serious possi-
bility of the introduction of further YFV-group viruses 
into Australia. We recommend that virulence studies 
in mouse models of both Sepik and the EHV variant 
be performed to assess risks of disease in man.
Table 2. Binding patterns of monoclonal antibodies as determined by ELISA when tested with EhV isolates and a selection 
of flaviviruses.
Viruses mAbs prepared to eHV strain c281 mAbs prepared to eHV strain pH235
3D11a 6A9a 7c6a 8G2b 3B11b 3G1c 5D3c 7c3c 6F7b
EhV C281* + + + + + + + + +
EhV ph235* + + + + + + + + +
EhV 26314 + + + + w w - w +
EhV p1553 + + + + - - - - +
EhV V366 + + + + - - - - +
BANV - - - + - - - - -
YFV - + - - - - - - -
SEpV - - + + - - - - +
DENV 1 - - - - - - - - -
DENV 2 - - - - - - - - -
DENV 3 - - - - - - - - -
DENV 4 - - - - - - - - -
MVEV - - NT - - - - - -
KoKV** - - NT - - - - - -
mAbs prepared to DenV 2 mAbs prepared to DenV 1, 2, 3 or 417
1D1b 2c5-2b 3A9b 3B2-1b 15F3c 3H5b 5D4c 1H10c 2H2a
EhV C281* + - - - - - - - -
EhV ph235* + - - - - - - - -
EhV 26314 + - - - - - - - -
EhV p1553 + - - - - - - - -
EhV V366 + - - - - - - - -
BANV + - - - - - - - -
YFV + - - - - - - - -
DENV 1 + - + + + - - - +
DENV 2 + + + + - + - - +
DENV 3 + - + - - - + - +
DENV 4 + - - - - - - + +
MVEV + - - - NT - - NT NT
KoKV** + - - - NT - - NT NT
Legend: +, positive; -, negative; w, weak reaction; NT, not tested.
*C281, ph235 and other EhV isolates (except 26314, p1553 and V366) had identical reaction patterns.
Viral protein reactivity of some mAbs was determined by Western blot under non-reducing conditions: aAntibodies 3B11, 6A9, 7C6, and 2h2 bind to 
prM. bAntibodies 8G2, 6F7, 1D1, 2C5-2, 3A9, 3B2-1 and 3h5 bind to E. cViral protein recognized by 3G1, 5D3, 7C3, 15F3, 5D4 and 1h10 could not be 
determined by Western blot. **Kokobera virus (KoKV).
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Figure 1. phylogenic analysis of EHV nucleotide sequences. EHV and other mosquito-borne flavivirus nucleotide sequences (660 nucleotides) of the 
NS5 gene were aligned using Clustal W.23 phylogenetic analysis was performed with the phYLIp analysis package24 using the following parameters: DNA 
distances were obtained from the Kimura 2-parameter algorithm, phylogenetic relationships determined with the neighbour-joining algorithm, and statisti-
cal significance of clusters calculated by bootstrapping 100 replicates and subsequent determination of consensus trees. Bootstrap (B) values are shown 
in the grey italics, and percent nucleotide similarity (nt) is shown in blue. EhV strains are shown in red, whereas EhV variants are shown in green. Scale 
bar indicates the distance length of 10 percent divergence.
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